News
The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...
The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...
Britain's blue-chip index notched its 15th consecutive session of gains - its longest winning streak on record - as investors ...
Canadian oil producer Imperial Oil posted a rise in first-quarter profit on Friday, driven primarily by stronger margins in ...
India's markets regulator has alleged Pranav Adani, director of several Adani group companies and the nephew of the ...
A federal judge on Friday said she will allow expert testimony that formula made by Abbott Laboratories and Reckitt Benckiser ...
TikTok was fined 530 million euros ($600 million) by its lead EU privacy regulator on Friday over concerns on how it protects ...
In an internal memo, the World Health Organization signaled its support for anti-obesity drugs like Wegovy and Zepbound, ...
In 2023, experts decided against adding obesity drugs to the World Health Organisation's essential medicines list.
Viking is developing what might be a game-changing medication in the segment. Viking Therapeutics (NASDAQ: VKTX), a biotech ...
11hon MSN
The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new study published Wednesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results